Navigation Links
Secrets of immune response illuminated in new study
Date:2/9/2012

ls survive in the host in an inactive state, "remembering" the cognate antigen to which they are related. Should they re-encounter this antigen, they can speedily mount a response, liberating IFN-λ.

An understanding of how IFN-λ release is regulated and the complex pathways involved in the production of this key cytokine remains incomplete. The current study demonstrates that the release of IFN-λ by memory T cells can also occur without the activation of these cells by direct contact with the disease antigen. In this way, memory CD8+ T cells also contribute to the host's innate immune response.

The mechanism for this antigen-independent immune response is the focus of the current study. The team's results significantly advance the understanding of such pathways and their subtle regulation, and may stimulate new biomedical approaches to interfering with and disabling disease-causing intruders.

In the new study, the group found that the antigen-independent production of IFN-λ by memory T cells relies on another cell type, known as splenic dendritic cells. Such cells contain so-called NOD-like receptors (NLRs). The NLR's are able to sniff out pathogen-associated molecular patterns. When they sense these distinctive patterns, the NLRs sound the alert.

While their more familiar cousins, the TOLL-like receptors, sense pathogen-associated molecular patterns in the extracellular space, NLRs sense pathogenic traces in the intracellular compartments. Further, once NLR's have successfully detected their target, they assemble large protein complexes in the dendritic cell, known as inflammasomes.

In the case of bacterial invasion, the NLR inside the splenic dendritic cell is triggered when it senses flagellina protein associated with bacterial flagellum. The NLR then assembles the inflammasome complex, which produces two key pro-inflammatory interleukinsIL-1 and IL-18. It is the second of these that will migrate f
'/>"/>

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Scientists look to microbes to unlock Earths deep secrets
2. Swarms of bees could unlock secrets to human brains
3. Learning secrets of worlds most common organic compound driving research for biofuels
4. As the worm turns, its secrets are revealed
5. Beetle bling: Researchers discover optical secrets of metallic beetles
6. MSU lands $4.1 million grant to unlock plants biochemistry secrets
7. Secrets of a precision protein machine
8. Breaking the mucus barrier unveils cancer cell secrets
9. Uncovering the genome secrets of the Blackleg fungus
10. A pesky bacterial slime reveals its survival secrets
11. Unlocking the secrets of a plants light sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Secrets of immune response illuminated in new study
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/5/2015)... Conn. , May 5, 2015, NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, reminds ... Company,s Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS ... May 5-7, 2015. The three-day conference is ... David is speaking in is themed Global Fraud: Where ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... COLD SPRING HARBOR, N.Y. (Jan. 15, 2009) ... in microscopy techniques, enabling biologists to understand the details ... before possible. In a new edition of the ... latest approaches join a large collection of established techniques--producing ...
... , , , , , , ... AUDIO: Professor Ian Graham, the Director of the Centre for Novel Agricultural Products at the University of York, UK, talks about ... for more information. , , , , ... , , , , , , , ...
... as HIV and HTLV-1 don,t hit-and-run, they hit-and-hide. They slip ... cell,s DNA, and from this refuge they establish an infection ... much less troublesome and much more manageable if the immune ... its first few days in the body, according to a ...
Cached Biology News:New edition of popular lab manual presents latest techniques for probing cellular dynamics 2New genetic map will speed up plant breeding of the world's most important medicinal crop 2New genetic map will speed up plant breeding of the world's most important medicinal crop 3New genetic map will speed up plant breeding of the world's most important medicinal crop 4Early immune response needed for hit-and-hide cancer viruses 2
(Date:5/26/2015)... , Kalifornien und HILDEN, Deutschland, May 26, ... Clinical Insight ®   ... und die Erstellung dazugehöriger Berichte; Vorstellung auf ... QIAGEN N.V. (NASDAQ: QGEN ... die Markteinführung von QIAGEN Clinical Insight ® ...
(Date:5/26/2015)... 26, 2015  Alere Inc. (NYSE: ALR ) (the ... to timely file its Quarterly Report on Form 10-Q for ... it has received a notice from the New York Stock ... with the NYSE,s continued listing requirements under the timely filing ... Manual. The reason for the delay relates ...
(Date:5/26/2015)... 2015   PDI , a leader in ... Oakwood Healthcare in Dearborn, Mich. ... in Delivering the Difference , ... in building collaborative relationships between infection prevention (IP) ... Oakwood Healthcare,s infection preventionist, ...
(Date:5/26/2015)... LOS ANGELES , 26. mája 2015 /PRNewswire/ ... ďakuje v mene svojej rodiny prezidentom Barackovi Obamovi ... vyjadrenú v súvislosti so stratou Dr. Rongxiang ... - http://photos.prnewswire.com/prnh/20150522/218111 Dr. Xu ... svojej dobe a jeho odhodlanie v oblasti vedy ...
Breaking Biology Technology:QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3Dr. Rongxiang Xu, O legende 2
... 6 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a ... today announced it has received US$2,500,000 from MannKind ... the option agreement and issuance of 2,400,000 units ... The transaction provides MannKind with the option to ...
... 6 Anacor Pharmaceuticals today,announced that it has ... participation from GlaxoSmithKline, Schering Corporation and existing,investors including ... Ventures. Proceeds from the financing will be ... its boron chemistry platform. , ...
... Va., Jan. 6 Star Scientific (Nasdaq :STSI) ... Inc., in conjunction with its Star Tobacco, Inc. ... ability of Stonewall(R) dissolvable smokeless tobacco to ... over-the-counter nicotine replacement product (NRT). The study, which ...
Cached Biology Technology:SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin 2SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin 3Anacor Raises $50 Million in Equity Financing 2Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation 2Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation 3Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation 4